In 2017, global revenue of artificial pancreas devices systems is nearly 55 M USD; the actual consumption is about 6900 units.
Thursday, 20 Sep, 2018

In the last several years, global market of artificial pancreas devices systems developed rapidly, with an average growth rate of 10%. In 2017, global revenue of artificial pancreas devices systems is nearly 55 M USD; the actual consumption is about 6900 units.

 

The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.

 

Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.

 

North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

 

Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.